Priorities for tuberculosis research: a systematic review
- PMID: 21050822
- PMCID: PMC2992175
- DOI: 10.1016/S1473-3099(10)70201-2
Priorities for tuberculosis research: a systematic review
Abstract
Reliable and relevant research can help to improve tuberculosis control worldwide. In recent years, various organisations have assessed research needs and proposed priorities for tuberculosis. We summarise existing priority statements and assess the rigour of the methods used to generate them. We found 33 documents that specifically outline priorities in tuberculosis research. The top priority areas were drug development (28 articles), diagnosis and diagnostic tests (27), epidemiology (20), health services research (16), basic research (13), and vaccine development and use (13). The most focused questions were on the treatment and prevention of multidrug-resistant tuberculosis in people co-infected with HIV. Methods used to identify these priorities were varied. Improvements can be made to ensure the process is more rigorous and transparent, and to use existing research or systematic reviews more often. WHO, Stop TB Partnership, and other organisations could adopt an incremental process of priority development, building on the existing knowledge base.
Copyright © 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views.Cochrane Database Syst Rev. 2022 Apr 26;4(4):CD014877. doi: 10.1002/14651858.CD014877.pub2. Cochrane Database Syst Rev. 2022. PMID: 35470432 Free PMC article.
-
Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.Cochrane Database Syst Rev. 2018 Aug 27;8(8):CD012768. doi: 10.1002/14651858.CD012768.pub2. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2021 Jan 15;1:CD012768. doi: 10.1002/14651858.CD012768.pub3. PMID: 30148542 Free PMC article. Updated.
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.Cochrane Database Syst Rev. 2016 May 10;(5):CD011420. doi: 10.1002/14651858.CD011420.pub2. Cochrane Database Syst Rev. 2016. PMID: 27163343 Free PMC article.
Cited by
-
Opportunities for improved serodiagnosis of human tuberculosis, bovine tuberculosis, and paratuberculosis.Vet Med Int. 2012;2012:674238. doi: 10.1155/2012/674238. Epub 2012 Jun 6. Vet Med Int. 2012. PMID: 22720192 Free PMC article.
-
Immunogenicity of mycobacterial vesicles in humans: identification of a new tuberculosis antibody biomarker.Tuberculosis (Edinb). 2013 Jul;93(4):448-55. doi: 10.1016/j.tube.2013.03.001. Epub 2013 Apr 2. Tuberculosis (Edinb). 2013. PMID: 23562367 Free PMC article.
-
Methods for Identifying Health Research Gaps, Needs, and Priorities: a Scoping Review.J Gen Intern Med. 2022 Jan;37(1):198-205. doi: 10.1007/s11606-021-07064-1. Epub 2021 Nov 8. J Gen Intern Med. 2022. PMID: 34748098 Free PMC article.
-
Scoping review of priority setting of research topics for musculoskeletal conditions.BMJ Open. 2018 Dec 16;8(12):e023962. doi: 10.1136/bmjopen-2018-023962. BMJ Open. 2018. PMID: 30559158 Free PMC article.
-
Plasma drug activity assay for treatment optimization in tuberculosis patients.Antimicrob Agents Chemother. 2011 Dec;55(12):5819-25. doi: 10.1128/AAC.05561-11. Epub 2011 Oct 3. Antimicrob Agents Chemother. 2011. PMID: 21968363 Free PMC article.
References
-
- WHO . Global tuberculosis control: a short update to the 2009 report. WHO/HTM/TB/2009426. World Health Organization; Geneva: 2009. http://whqlibdoc.who.int/publications/2009/9789241598866_eng.pdf (accessed July 1, 2010).
-
- WHO and Special Programme for Research and Training in Tropical Diseases (TDR) Priority setting methodologies in health research. World Health Organization; Geneva: April 10–11, 2008. http://apps.who.int/tdr/stewardship/pdf/Priority_setting_Workshop_Summar... (accessed July 1, 2010).
-
- Agarwal N. Tuberculosis research and development: a critical analysis of funding trends, 2005–2007 an update. Treatment Action Group; New York: March, 2009. http://www.treatmentactiongroup.org/uploadedFiles/About/Publications/TAG... (accessed July 1, 2010).
-
- Stop TB Partnership and WHO . The global plan to stop TB, 2006–2015. Stop TB Partnership and World Health Organization; Geneva: 2006. http://www.stoptb.org/assets/documents/global/plan/GlobalPlanFinal.pdf (accessed Aug 28, 2009).
-
- Council on Health Research for Development (COHRED) Priority setting for health research: toward a management process for low and middle income countries. COHRED; 2006. http://www.cohred.org/sites/default/files/WP1_PrioritySetting.pdf (accessed June 17, 2009).
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical